Introduction
There's a metabolic condition that affects a large proportion of women with insulin resistance and PCOS - one that progresses silently for years, produces no symptoms until significant damage has occurred, and is almost never checked for at a standard appointment. It's fatty liver disease, and its connection to insulin resistance is one of the most important and least discussed pieces of the metabolic picture in women's health.
If you have insulin resistance or PCOS, this matters to you - and it matters even if you're a normal weight, because fatty liver in this context isn't primarily about how much you weigh. It's about what insulin is doing to your liver. This article explains the connection, why it's so often missed, which tests to ask your doctor for, and the genuinely good news: caught early, it's largely reversible.
What fatty liver actually is
Fatty liver disease is exactly what it sounds like - the accumulation of excess fat in the liver. Until recently it was called non-alcoholic fatty liver disease (NAFLD); it's now more accurately known as metabolic dysfunction-associated steatotic liver disease (MASLD), a name change that - like the recent renaming of PCOS to PMOS - was made specifically to put the metabolic nature of the condition front and centre. The new name says it plainly: this is a condition of metabolic dysfunction.
Your liver is one of your body's most important metabolic organs, central to how you process and store energy. When fat begins to accumulate in liver tissue, the liver works less efficiently - and the process tends to progress quietly, over years, before producing any noticeable symptoms at all. That silence is exactly what makes it dangerous, and exactly why understanding the connection matters before symptoms ever appear.
Insight
Fatty liver isn't a drinking problem or simply an "overweight" problem. In women with insulin resistance and PCOS, it's a metabolic signalling problem - which is why it can develop in women who eat carefully and who are a perfectly normal weight.
The connection: how insulin resistance drives fatty liver
The link between insulin resistance and fatty liver is direct, mechanical, and well established. Here's how it works.
When you're insulin resistant, your cells stop responding well to insulin, so your pancreas produces more of it to compensate. That chronically elevated insulin doesn't just affect your blood sugar - it acts directly on your liver, stimulating it to ramp up fat production through a process called hepatic de novo lipogenesis. In plain terms: high insulin instructs your liver to manufacture new fat from glucose and store it in its own tissue.
This is the crucial insight, and it's why the condition behaves so differently from what most people assume. The fat accumulating in the liver isn't simply dietary fat you've eaten - it's fat your own liver is making, on the instruction of elevated insulin. As one clinical summary puts it, this is a signalling problem, not a diet problem. Which means a woman can eat carefully, even impeccably, and still develop liver fat, because the underlying insulin resistance is running in the background driving the process regardless.
The relationship also becomes a vicious cycle: liver fat worsens insulin resistance, and worsening insulin resistance drives more liver fat. Each feeds the other. This is why understanding whether you're insulin resistant is the entry point to understanding your liver health too.
Why women with PCOS are at particular risk
For women with PCOS (now also known as PMOS), this connection is especially important, because the risk is substantially elevated. Research consistently finds that women with PCOS are several times more likely to develop fatty liver disease than women without it - and the elevated risk holds regardless of body weight.
Three mechanisms link PCOS and fatty liver, and they overlap:
- Insulin resistance - the central driver, present in the majority of women with PCOS, and the strongest predictor of liver fat accumulation.
- Androgen excess - the elevated male hormones characteristic of PCOS independently contribute to liver fat, which is why women with the more hyperandrogenic form of PCOS tend to have higher liver fat even after accounting for insulin resistance and weight. The way high insulin drives these androgens ties the whole picture together.
- Chronic inflammation - a feature of both conditions that perpetuates the metabolic dysfunction.
Because these are the same mechanisms that drive PCOS itself, fatty liver isn't a separate, unlucky coexisting condition - it's another downstream consequence of the same metabolic dysfunction. Treating one without addressing the other consistently produces incomplete results.
The lean women nobody warns
Here's the part that surprises women most, and the part that makes this article worth reading even if you don't fit the stereotype.
Fatty liver in the context of insulin resistance and PCOS occurs in normal-weight women, not only in those who are overweight. Because the driver is insulin signalling rather than body size, a slim woman with lean PCOS - or a normal-weight woman with hidden insulin resistance - can have meaningful liver fat while looking entirely "healthy" on the outside and being reassured that she's fine.
This is the same trap we describe across this site: the woman who's a normal weight, whose standard bloods look acceptable, who's told there's nothing wrong - while a genuine metabolic process advances unseen. Fatty liver is one of the clearest examples of why "you look well" and "you are metabolically well" are not the same thing.
Insight
You do not have to be overweight to have fatty liver. If you have insulin resistance or PCOS, the metabolic process that drives liver fat can be running regardless of your size - which is precisely why it's so often missed in slim women.
Why your doctor probably hasn't checked
This is where it becomes actionable. Despite how common and consequential fatty liver is in women with insulin resistance and PCOS, it is routinely not screened for. Most women are never offered liver testing at a PCOS diagnosis, and because fatty liver produces no symptoms until it's advanced, there's nothing to prompt a check.
The result is a silent gap in care: a condition that's common, consequential, progressive, and reversible if caught early - going undetected because nobody looks. As with so much in women's metabolic health, the issue isn't that nothing is wrong; it's that the right thing isn't being measured. This is the same problem we describe in why "normal" blood tests can miss what's really happening.
Tests worth asking your doctor about if you have insulin resistance or PCOS:
- Liver enzymes (ALT, AST) - a basic blood test that can flag liver stress, though it can be normal even when liver fat is present, so it's a starting point rather than a definitive answer.
- A liver ultrasound or FibroScan - imaging that can detect and assess liver fat directly.
- Fasting insulin and HOMA-IR - to assess the underlying insulin resistance driving the process.
The decision about which tests are appropriate, and the interpretation of any liver findings, belongs with your doctor - fatty liver is a medical diagnosis. But knowing to ask is often the missing step, because the testing rarely happens unprompted.
The good news: it's largely reversible
Here's why this article isn't cause for alarm but for action. Early fatty liver - before it progresses to inflammation and scarring - is one of the more reversible metabolic conditions there is. And because it's driven by insulin resistance, the very same approach that improves insulin sensitivity also reduces liver fat. You're not treating two conditions; you're addressing one underlying driver.
The foundations that help:
Stabilise blood sugar and lower the insulin load. Since elevated insulin is what instructs the liver to make fat, reducing the insulin signal is the highest-leverage intervention. Building meals around protein, fat, and fibre to flatten blood sugar - the foundation we cover in balancing blood sugar - directly addresses the driver.
Reduce refined carbohydrates and added sugar - especially fructose. The liver is particularly involved in processing fructose, and excess sugar intake is a significant contributor to liver fat. This is one area where dietary change acts almost directly on the liver.
Address insulin resistance comprehensively. Everything that reverses insulin resistance naturally - nutrition, movement, sleep, stress, protein, muscle - reduces liver fat too, because they share the same root.
These principles work for most women. But there's a reason a personalised approach matters here especially.
Why the right approach is specific to you
Because fatty liver is driven by your individual insulin response, the foods that best protect your liver aren't identical to the next woman's.
This is well established in nutrition science. Research tracking how thousands of people respond to identical meals shows the same food can spike one woman's blood sugar and insulin sharply - driving the hepatic fat production we've described - while another tolerates it easily. So the most effective way to reduce the insulin signal driving liver fat is to know which foods produce a calm insulin response in your body specifically.
This is why the most effective approach to the insulin resistance underlying fatty liver is a personalised one: using a detailed picture of your individual biochemistry to identify the specific foods that calm your insulin response and protect your metabolic health, and building your nutrition around those. It's the foundation of the personalised metabolic and nutrition programmes that address the root driver - the insulin resistance - rather than applying generic liver-diet advice, because the metabolic dysfunction behind fatty liver is exactly what individualised nutrition is designed to correct.
Clinical Insight
The association between insulin resistance and hepatic steatosis - now classified as metabolic dysfunction-associated steatotic liver disease (MASLD), reflecting the formal recognition of its metabolic aetiology - represents one of the most clinically significant and under-recognised dimensions of metabolic health in women.
The mechanism is direct: compensatory hyperinsulinaemia secondary to insulin resistance stimulates hepatic de novo lipogenesis, driving the synthesis and intrahepatic storage of fat independent of dietary fat intake, while hepatic fat accumulation in turn exacerbates insulin resistance, establishing a self-reinforcing cycle.
In women with PCOS/PMOS the prevalence is markedly elevated - estimates place the risk at two- to four-fold that of unaffected women - and, critically, this elevation is substantially independent of body mass index: hyperandrogenism and insulin resistance contribute to hepatic lipid accumulation in normal-weight women, such that lean phenotypes are by no means exempt.
The clinical concern is compounded by the condition's silent natural history; hepatic steatosis is typically asymptomatic until advanced, and liver enzymes may remain within normal limits despite significant steatosis, meaning that routine screening is both inadequate and infrequently performed at PCOS diagnosis. This constitutes a meaningful gap in care, given that early steatosis, prior to the development of steatohepatitis and fibrosis, is substantially reversible.
Because the condition shares its principal driver - insulin resistance - with PCOS itself, the therapeutic priority is identical: reduction of the chronic insulin load through glycaemic stabilisation, attenuation of refined carbohydrate and fructose intake, and comprehensive improvement of insulin sensitivity.
Appropriate assessment includes hepatic imaging and direct measurement of insulin alongside liver enzymes, with diagnosis and monitoring remaining within the medical domain; nutritional intervention targeting the underlying insulin resistance, calibrated to individual metabolic response, is the foundation of reversal, since hepatic and glycaemic responses to specific dietary patterns vary substantially between individuals.
Working With the Metabolic Drivers Behind Fatty Liver?
If you have insulin resistance or PCOS, your liver health is part of the same metabolic picture - and addressing the insulin resistance underneath is what protects it. My metabolic health programmes begin with a comprehensive analysis of your individual blood chemistry, looking at what's actually happening with your insulin and metabolism, then build a personalised nutrition plan around your biochemistry to reduce the insulin signal driving fat accumulation and support your metabolic health at the root.
Because the same insulin resistance drives fatty liver, PCOS symptoms, and so much else, women often find that addressing it properly improves the whole picture together - not one isolated problem at a time.
Note: fatty liver is a medical diagnosis. If you're concerned, your doctor is the right person to arrange testing and interpret results. This programme focuses on the nutritional approach to the underlying insulin resistance, alongside your medical care.
👉 Book a 1:1 Health Strategy Session
In-clinic and remote consultations available.
Free resource
Download the 7-Day Metabolic Reset Guide - a free, clinically grounded place to start reducing the insulin load that drives liver fat. Blood-sugar-stabilising, protein-led, and designed specifically for women. No supplement lists. No extreme protocols.
Frequently Asked Questions
Can you have fatty liver without being overweight?
Yes. In women with insulin resistance or PCOS, fatty liver is driven by insulin signalling rather than body weight, so it occurs in normal-weight and lean women too. This is one reason it's so often missed in women who appear healthy.
How does insulin resistance cause fatty liver?
When you're insulin resistant, chronically elevated insulin acts on the liver and stimulates it to produce new fat from glucose (a process called de novo lipogenesis), which is stored in the liver. It's a signalling process driven by insulin, not simply a result of eating fatty food.
Are women with PCOS more likely to get fatty liver?
Yes - research consistently finds women with PCOS are several times more likely to develop fatty liver disease than women without it, regardless of weight, because they share the same drivers: insulin resistance, androgen excess, and inflammation.
What tests show fatty liver?
Liver enzymes (ALT, AST) are a starting point but can be normal even with liver fat present. A liver ultrasound or FibroScan can detect liver fat directly. Fasting insulin and HOMA-IR assess the underlying insulin resistance. Your doctor can advise which are appropriate for you.
Is fatty liver reversible?
Early fatty liver, before it progresses to inflammation and scarring, is largely reversible. Because it's driven by insulin resistance, the same approach that improves insulin sensitivity - stabilising blood sugar, reducing refined carbohydrates and sugar, and addressing insulin resistance through nutrition - also reduces liver fat.





